Updates

CSRxP LAUNCHES SIX-FIGURE ADVERTISING CAMPAIGN TO HOLD BIG PHARMA ACCOUNTABLE FOR ANTICOMPETITIVE PRACTICES AND EGREGIOUS DRUG PRICING

Apr 28, 2025

Campaign Spoofs Big Pharma’s Direct-to-Consumer (DTC) Ads While Highlighting Read More

DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE EXTENDING MONOPOLIES, KEEPING PRICES HIGH ON GLP-1S

Apr 22, 2025

Novo Nordisk Alone Has Filed 320 Patents on Single Active Ingredient Behind Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Apr 16, 2025

Big Pharma Giant Johnson & Johnson Reports Earnings That Beating Wall Read More

CSRxP STATEMENT ON U.S. SENATE AND U.S. HOUSE REINTRODUCTION OF Q1/Q2 REFORMS TO FOSTER GREATER COMPETITION, LOWER DRUG PRICES

Apr 15, 2025

Lawmakers Should Advance Bipartisan Solution to Crack Down on Anti-Competitive Read More

THEY SAID IT! SENATE JUDICIARY CALLS OUT BIG PHARMA’S ANTI-COMPETITIVE PRACTICES THAT KEEP PRESCRIPTION DRUG PRICES HIGH

Apr 7, 2025

Senators on Both Sides of the Aisle Highlight Concerns with Big Pharma’s Read More

BIG PHARMA WATCH: PFIZER AVOIDED PAYING BILLIONS IN U.S. TAXES THROUGH “EGREGIOUS TAX GIMMICK”

Apr 2, 2025

Big Pharma Giant Used “Round-Tripping” Tax Avoidance Scheme to Attribute Read More

FACT SHEET: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS, TAXPAYERS AND THE U.S. HEALTH CARE SYSTEM BILLIONS OF DOLLARS

Apr 2, 2025

BIG PHARMA’S PATENT ABUSE IS THE ROOT CAUSE OF OUT-OF-CONTROL PRESCRIPTION Read More

CSRxP ANALYSIS FINDS BIG PHARMA’S DIRECT-TO-CONSUMER (DTC) ADVERTISING COSTS U.S. TAXPAYERS BILLIONS OF DOLLARS

Mar 18, 2025

Study Finds Reducing or Taxing Brand Name Drug Companies’ Nearly $14 Billion Read More

They Said It!: Lawmakers And FDA Nominee Highlight Greater Competition As Critical To Lowering Prescription Drug Prices

Mar 12, 2025

U.S. Senate Confirmation Hearing Called Attention to Big Pharma’s Egregious Read More

ICYMI: CSRxP SURVEY FINDS AMERICAN VOTERS OVERWHELMINGLY HOLD BIG PHARMA RESPONSIBLE FOR HIGH DRUG PRICES

Mar 6, 2025

Across Political Spectrum, Fabrizio Ward Finds Voters Identify Pharmaceutical Read More